Ductal carcinoma in situ: Recent advances and future prospects

International Journal of Surgical Oncology

Volumn 2012, Issue , 2012, Pages

  Lambert, Kelly ^a   Patani, Neill ^b   Mokbel, Kefah ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b Princess Grace Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866178767     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2012/347385     Document Type: Review

References (105)

1. Lippman M., Silverstein M. J., Recht A., Lagios M., Why study ductal carcinoma in-situ? Ductal Carcinoma In-situ of the Breast 2002 2nd Philadelphia, Pa, USA Lippincott Williams & Wilkins 12 16
2. Netter E., Troufleau P., Stines J., Ductal carcinoma in-situ of the breast: role of imaging. Journal De Radiologie 1998 79 7 651 658 (Pubitemid 28332274)
3. Sumner W. E. III, Koniaris L. G., Snell S. E., Spector S., Powell J., Avisar E., Moffat F., Livingstone A. S., Franceschi D., Results of 23,810 cases of ductal carcinoma in-situ. Annals of Surgical Oncology 2007 14 5 1638 1643 2-s2.0-34249100946 10.1245/s10434-006-9316-1 (Pubitemid 46791002)
4. Bobo J. K., Lee N. C., Thames S. F., Findings from 752081 clinical breast examinations reported to a national screening program from 1995 through 1998. Journal of the National Cancer Institute 2000 92 12 971 976 2-s2.0-0034697562 (Pubitemid 30469962)
5. Ernster V. L., Barclay J., Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. Journal of the National Cancer Institute. Monographs 1997 22 151 156 2-s2.0-0031322938
6. Virnig B. A., Tuttle T. M., Shamliyan T., Kane R. L., Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. Journal of the National Cancer Institute 2010 102 3 170 178 2-s2.0-76349106646 10.1093/jnci/djp482
7. Sorum R., Hofvind S., Skaane P., Haldorsen T., Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. The Breast Journal 2010 19 6 499 505 2-s2.0-78349310834 10.1016/j.breast.2010. 05.014
8. Pisano E., Gatsonia C., Hendrick E., Diagnostic performance of digital versus film mammography for breast-cancer screening. The New England Journal of Medicine 2005 353 17 1773 1783 10.1056/NEJMoa052911 (Pubitemid 41549889)
9. Boetes C., Veltman J., Screening women at increased risk with MRI. International Cancer Imaging Society 2005 5 A S10 S15 10.1102/1470-7330.2005. 0040 2-s2.0-33644995588
10. Menell J. H., Morris E. A., Dershaw D. D., Abramson A. F., Brogi E., Liberman L., Determination of the presence and extent of pure ductal carcinoma in-situ by mammography and magnetic resonance imaging. The Breast Journal 2005 11 6 382 390 2-s2.0-28544453295 10.1111/j.1075-122X.2005.00121.x (Pubitemid 41743410)
11. Allegra C., Aberle D., Ganschow P., Hahn S., Lee C., Millon-Underwood S., Pike M., Reed S., Saftlas A., Scarvalone S., Schwartz A., Slomski C., Yothers G., Zon R., National institutes of health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ september 2224, 2009. Journal of the National Cancer Institute 2010 102 3 161 169 2-s2.0-76349088705 10.1093/jnci/djp485
12. Kuhl C. K., Schrading S., Bieling H. B., Wardelmann E., Leutner C. C., Koenig R., Kuhn W., Schild H. H., MRI for diagnosis of pure ductal carcinoma in-situ: a prospective observational study. The Lancet 2007 370 9586 485 492 2-s2.0-34547655642 10.1016/S0140-6736(07)61232-X (Pubitemid 47214635)
13. Schouten van der Velden A. P., Schlooz-Vries M. S., Boetes C., Wobbes T., Magnetic resonance imaging of ductal carcinoma in-situ: what is its clinical application? a review. American Journal of Surgery 2009 198 2 262 269 2-s2.0-67650725827 10.1016/j.amjsurg.2009.01.010
14. Warner E., Causer P. A., Wong J. W. N., Wright F. C., Jong R. A., Hill K. A., Messner S. J., Yaffe M. J., Narod S. A., Plewes D. B., Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study. The Breast Journal 2011 17 1 9 17 2-s2.0-79251469079 10.1111/j.1524-4741.2010.01018. x
15. Mokbel K., Escobar P. F., Matsunaga T., Mammary ductoscopy: current status and future prospects. European Journal of Surgical Oncology 2005 31 1 3 8 2-s2.0-12144255516 10.1016/j.ejso.2004.10.004 (Pubitemid 40103917)
16. Going J. J., Moffat D. F., Escaping from flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions. Journal of Pathology 2004 203 1 538 544 2-s2.0-1942499761 10.1002/path.1556 (Pubitemid 38529033)
17. Zhao L., Freimanis R., Bergman S., Shen P., Perrier N. D., Lesko N., Pulaski T., Pulaski S., Carr J. J., Levine E. A., Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities. American Surgeon 2003 69 9 757 762 2-s2.0-1542751675
18. Pinder S., Duggan C., Ellis I., A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. British Journal of Cancer 2010 103 1 94 100 10.1038/sj.bjc.6605718
19. Douglas-Jones A. G. M., Morgan J. M., Appleton M. A. C., Consistency in the observation of features used to classify duct carcinoma in-situ (DCIS) of the breast. Journal of Clinical Pathology 2000 53 8 596 602 2-s2.0-0033888965 10.1136/jcp.53.8.596 (Pubitemid 30640170)
20. Bethwaite P., Smith N., Delahunt B., Kenwright D., Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast. Journal of Clinical Pathology 1998 51 6 450 454 2-s2.0-0031836171 (Pubitemid 28312177)
21. Ellis I. O., Coleman D., Wells C., Kodikara S., Paish E. M., Moss S., Al-Sam S., Anderson N., Bobrow L., Buley I., Connolly C. E., Dallimore N. S., Hales S., Hanby A., Humphreys S., Knox F., Lowe J., Macartney J., Nash R., Parham D., Patnick J., Pinder S. E., Quinn C. M., Robertson A. J., Shrimankar J., Walker R. A., Winder R., Impact of a national external quality assessment scheme for breast pathology in the UK. Journal of Clinical Pathology 2006 59 2 138 145 2-s2.0-32544450858 10.1136/jcp.2004.025551 (Pubitemid 43235576)
22. Lester S. C., Bose S., Chen Y. Y., Connolly J. L., De Baca M. E., Fitzgibbons P. L., Protocol for the examination of specimens from patients with ductal carcinoma in-situ of the breast. Archives of Pathology and Laboratory Medicine 2009 133 1 15 25
23. Silverstein M. J., Poller D. N., Waisman J. R., Colburn W. J., Barth A., Gierson E. D., Lewinsky B., Gamagami P., Slamon D. J., Prognostic classification of breast ductal carcinoma-in-situ. The Lancet 1995 345 8958 1154 1157 2-s2.0-0029021632
24. Poller D. N., Silverstein M. J., Galea M., Locker A. P., Elston C. W., Blamey R. W., Ellis I. O., Ideas in pathology. ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Modern Pathology 1994 7 2 257 262 2-s2.0-0028380986
25. Betsill W. L., Rosen P. P., Lieberman P. H., Robbins G. F., Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. Journal of the American Medical Association 1978 239 18 1863 1867 2-s2.0-0018093363 10.1001/jama.239.18.1863 (Pubitemid 8322874)
26. Sanders M. E., Schuyler P. A., Dupont W. D., Page D. L., The natural history of low-grade ductal carcinoma in-situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005 103 12 2481 2484 2-s2.0-20444379234 10.1002/cncr.21069 (Pubitemid 40800525)
27. Leonard G. D., Swain S. M., Ductal carcinoma in-situ, complexities and challenges. Journal of the National Cancer Institute 2004 96 12 906 920 2-s2.0-2942672535 (Pubitemid 38868137)
28. Kerlikowske K., Molinaro A., Cha I., Ljung B. M., Ernster V. L., Stewart K., Chew K., Moore D. H., Waldman F., Characteristics associated with recurrence among women with ductal carcinoma in-situ treated by lumpectomy. Journal of the National Cancer Institute 2003 95 22 1692 1702 2-s2.0-0345099342 (Pubitemid 37509078)
29. Bijker N., Peterse J. L., Duchateau L., Julien J. P., Fentiman I. S., Duval C., Di Palma S., Simony-Lafontaine J., De Mascarel I., Van de Vijver M. J., Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in-situ: analysis of european organization for research and treatment of cancer trial 10853. Journal of Clinical Oncology 2001 19 8 2263 2271 2-s2.0-0035871577 (Pubitemid 32366979)
30. Nakhlis F., Morrow M., Ductal carcinoma in-situ. Surgical Clinics of North America 2003 83 4 821 839 2-s2.0-0038495608
31. Ben-David M. A., Sturtz D. E., Griffith K. A., Douglas K. R., Hayman J. A., Lichter A. S., Pierce L. J., Long-term results of conservative surgery and radiotherapy for ductal carcinoma in-situ using lung density correction: the University of Michigan experience. The Breast Journal 2007 13 4 392 400 2-s2.0-34250822214 10.1111/j.1524-4741.2007.00447.x (Pubitemid 46985566)
32. Di Saverio S., Catena F., Santini D., Ansaloni L., Fogacci T., Mignani S., Leone A., Gazzotti F., Gagliardi S., De Cataldis A., Taffurelli M., 259 patients with DCIS of the breast applying USC/van nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Research and Treatment 2008 109 3 405 416 2-s2.0-43749089413 10.1007/s10549-007-9668-7 (Pubitemid 351692055)
33. Vicini F. A., Recht A., Age at diagnosis and outcome for women with ductal carcinoma in-situ of the breast: a critical review of the literature. Journal of Clinical Oncology 2002 20 11 2736 2744 2-s2.0-0036605570 10.1200/JCO.2002.07.137 (Pubitemid 34575647)
34. Wang S. Y., Shamliyan T., Virnig B. A., Kane R., Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Research and Treatment 2011 127 1 1 14 2-s2.0-79851509160 10.1007/s10549-011-1387-4
35. Fisher B., Land S., Mamounas E., Dignam J., Fisher E. R., Wolmark N., Prevention of invasive breast cancer in women with ductal carcinoma in-situ: an update of the national surgical adjuvant breast and bowel project experience. Seminars in Oncology 2001 28 4 400 418 2-s2.0-0034883290 (Pubitemid 32762083)
36. Schwartz G. F., Solin L. J., Olivotto I. A., Consensus Conference on the treatment of in situ Ductal Carcinoma of the breast, April 22-25,1999. Cancer 2000 88 4 946 954 10.1002/(SICI)1097-0142(20000215)88:4946::AID-CNCR26>3.0. CO;2-5 (Pubitemid 30091115)
37. Cutuli B., Cohen-Solal-le Nir C., De Lafontan B., Mignotte H., Fichet V., Fay R., Servent V., Giard S., Charra-Brunaud C., Lemanski C., Auvray H., Jacquot S., Charpentier J. C., Breast conserving therapy for ductal carcinoma in-situ of the breast: the French Cancer Centers' experience. International Journal of Radiation Oncology Biology Physics 2002 53 4 868 879 2-s2.0-0037100126 10.1016/S0360-3016(02)02834-1 (Pubitemid 34722631)
38. Cutuli B., Lemanski C., Le Blanc M., Local recurrences after DCIS therapy: diagnosis, treatment and outcome. Breast Cancer Research and Treatment 2002 76, supplement 1, article A31 36
39. MacDonald H. R., Silverstein M. J., Mabry H., Moorthy B., Ye W., Epstein M. S., Holmes D., Silberman H., Lagios M., Local control in ductal carcinoma in-situ treated by excision alone: incremental benefit of larger margins. American Journal of Surgery 2005 190 4 521 525 2-s2.0-24944546453 10.1016/j.amjsurg.2005.06.005 (Pubitemid 41306068)
40. Neuschatz A. C., DiPetrillo T., Steinhoff M., Safaii H., Yunes M., Landa M., Chung M., Cady B., Wazer D. E., The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in-situ of the breast. Cancer 2002 94 7 1917 1924 2-s2.0-0036534309 10.1002/cncr.10460 (Pubitemid 34270043)
41. Cutuli B, Fourquet A, Luporsi E, Standards, Options et Recommendations 2004. Prise en charge des carcinomes canalaires in-situ du sein. Bulletin du Cancer 2005 92 2 155 168 (Pubitemid 40396123)
42. Dunne C., Burke J. P., Morrow M., Kell M. R., Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. Journal of Clinical Oncology 2009 27 10 1615 1620 2-s2.0-63749086807 10.1200/JCO.2008.17.5182
43. Park C., Schmitt J., Silverstein M. J., Recht A., Lagios M., Joint center for radiation therapy experience. Ductal Carcinoma in-situ of the Breast 2002 2nd Philadelphia, Pa, USA Lippincott Williams & Wilkins 373 380
44. Phillips L. S., Millikan R. C., Schroeder J. C., Barnholtz-Sloan J. S., Levine B. J., Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiology Biomarkers and Prevention 2009 18 5 1507 1514 2-s2.0-66549100724 10.1158/1055-9965.EPI-08-0967
45. Silverstein M. J., The University of Southern California/Van Nuys prognostic index for ductal carcinoma in-situ of the breast. American Journal of Surgery 2003 186 4 337 343 2-s2.0-0142182087 10.1016/S0002-9610(03)00265-4 (Pubitemid 38368606)
46. Silverstein M. J., An argument against routine use of radiotherapy for ductal carcinoma in-situ. Oncology 2003 17 11 1511 1533 2-s2.0-2142838402
47. Baqai T., Shousha S., Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast. Histopathology 2003 42 5 440 447 2-s2.0-0038531075 10.1046/j.1365-2559.2003.01612.x (Pubitemid 36605586)
48. Provenzano E., Hopper J. L., Giles G. G., Marr G., Venter D. J., Armes J. E., Biological markers that predict clinical recurrence in ductal carcinoma in-situ of the breast. European Journal of Cancer 2003 39 5 622 630 2-s2.0-0242380840 10.1016/S0959-8049(02)00666-4 (Pubitemid 36287374)
49. Roses R. E., Paulson E. C., Sharma A., Schueller J. E., Nisenbaum H., Weinstein S., Fox K. R., Zhang P. J., Czerniecki B. J., Her-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiology Biomarkers and Prevention 2009 18 5 1385 1389 2-s2.0-66549130199 10.1158/1055-9965.EPI-08-1101
50. Sorlie T., Perou C. M., Tibshirani R., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America 2001 98 19 10869 10874 (Pubitemid 32878711)
51. Clark S., Warwick J., Carpenter R., Bowen R. L., Duffy S. W., Jones J. L., Molecular subtyping of dcis: heterogeneity of breast cancer reflected in pre-invasive disease. British Journal of Cancer 2011 104 1 120 127 2-s2.0-78650907795 10.1038/sj.bjc.6606021
52. Buerger H., Otterbach F., Simon R., Poremba C., Diallo R., Decker T., Riethdorf L., Brinkschmidt C., Dockhorn-Dworniczak B., Boecker W., Comparative genomic hybridization of ductal carcinoma in-situ of the breastevidence of multiple genetic pathways. Journal of Pathology 1999 187 4 396 402 10.1002/(SICI)1096-9896(199903)187:4396::AID-PATH286>3.0.CO;2-L (Pubitemid 29118269)
53. Aubele M., Mattis A., Zitzelsberger H., Extensive ductal carcinoma in-situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. International Journal of Cancer 2000 85 1 82 86
54. Hannemann J., Velds A., Halfwerk J. B. G., Kreike B., Peterse J. L., Van de Vijver M. J., Classification of ductal carcinoma in-situ by gene expression profiling. Breast Cancer Research 2006 8 5, article R61 2-s2.0-33751353068 10.1186/bcr1613 (Pubitemid 44811695)
55. Balleine R. L., Webster L. R., Davis S., Salisbury E. L., Palazzo J. P., Schwartz G. F., Cornfield D. B., Walker R. L., Byth K., Clarke C. L., Meltzer P. S., Molecular grading of ductal carcinoma in situ of the breast. Clinical Cancer Research 2008 14 24 8244 8252 2-s2.0-58149340467 10.1158/1078-0432.CCR- 08-0939
56. Wulfkuhle J. D., Sgroi D. C., Krutzsch H., McLean K., McGarvey K., Knowlton M., Chen S., Shu H., Sahin A., Kurek R., Wallwiener D., Merino M. J., Petricoin E. F., Zhao Y., Steeg P. S., Proteomics of human breast ductal carcinoma in-situ. Cancer Research 2002 62 22 6740 6749 2-s2.0-0037112454 (Pubitemid 35364146)
57. Gotte M., Kersting C., Radke I., Kiesel L., Wulfing P., An expression signature of syndecan-1 (cd138), e-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in-situ. Breast Cancer Research 2007 9 1, article R8 2-s2.0-34248212890 10.1186/bcr1641 (Pubitemid 350215153)
58. Gonzalez L. O., Junquera S., del Casar J. M., Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast. Human Pathology 2010 41 7 980 989 2-s2.0-77953285948 10.1016/j.humpath.2009.08.027
59. Morrow M., Strom E. A., Bassett L. W., Standard for the management of ductal carcinoma in-situ of the breast (DCIS). CA: A Cancer Journal for Clinicians 2002 52 5 256 276 2-s2.0-0036755627 (Pubitemid 35345498)
60. Boyages J., Delaney G., Taylor R., Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999 85 3 616 628 10.1002/(SICI)1097-0142(19990201)85:3616::AID-CNCR12>3.0.CO;2-7 (Pubitemid 29075283)
61. Douek M., Baum M., Mass breast screening: is there a hidden cost? The British Journal of Surgery 2003 90, supplement 1, article 14 44 45
62. Cutuli B., Lemanski C., Fourquet A., De Lafontan B., Giard S., Meunier A., Pioud-Martigny R., Campana F., Marsiglia H., Lancrenon S., Mery E., Penault-Llorca F., Fondrinier E., Tunon De Lara C., Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. British Journal of Cancer 2009 100 7 1048 1054 2-s2.0-63949083852 10.1038/sj.bjc.6604968
63. Cunnick G. H., Mokbel K., Skin-sparing mastectomy. American Journal of Surgery 2004 188 1 78 84 2-s2.0-3042583809 10.1016/j.amjsurg.2004.02.004 (Pubitemid 38823060)
64. Ottesen G. L., Graversen H. P., Blichert-Toft M., Christensen I. J., Andersen J. A., Carcinoma in-situ of the female breast. 10-year follow-up results of a prospective nation-wide study. Breast Cancer Research and Treatment 2000 62 3 197 210 2-s2.0-0033754785 10.1023/A:1006453915590
65. Ringberg A., Idvall I., Ferno M., Anderson H., Anagnostaki L., Boiesen P., Bondesson L., Holm E., Johansson S., Lindholm K., Ljungberg O., Ostberg G., Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in-situ of the breast. European Journal of Surgical Oncology 2000 26 5 444 451 2-s2.0-0033830381 10.1053/ejso.1999.0919
66. Cataliotti L., Distante V., Orzalesi L., Silverstein M. J., Recht A., Lagios M., The florence experience. Ductal Carcinoma In-situ of the Breast 2002 2nd Philadelphia, Pa, USA Lippincott Williams & Wilkins 348 353
67. Tunon De Lara C., De Mascarel I., Mac Grogan G., Analysis of 676 cases of ductal carcinoma in-situ (DCIS) of the breast from 1971 to 1995: diagnosis and treatment: the experience of one institute. American Journal of Clinical Oncology 2001 24 6 531 536 2-s2.0-0035205787 10.1097/00000421-200112000-00001 (Pubitemid 33131410)
68. Schwartz G. F., Silverstein M. J., Recht A., Lagios M., Treatment of subclinical ductal carcinoma in-situ of the breast by local excision and surveillance: an update personal experience. Ductal Carcinoma In-Situ of the Breast 2002 2nd Philadelphia, Pa, USA Lippincott Williams & Wilkins 308 321
69. Lagios M. D., Silverstein M. J., Ductal carcinoma in-situ: the success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. Surgical Oncology Clinics of North America 1997 6 2 385 392 2-s2.0-0030985734 (Pubitemid 27187742)
70. Arnesson L. G., Olsen K., Silverstein M. J., Linköping experience. Ductal Carcinoma In-Situ of the Breast 1997 Baltimore, Md, USA Williams & Wilkins 373 377
71. Solin L. J., Fourquet A., Vicini F. A., Taylor M., Olivotto I. A., Haffty B., Strom E. A., Pierce L. J., Marks L. B., Bartelink H., McNeese M. D., Jhingran A., Wai E., Bijker N., Campana F., Hwang W. T., Long-term outcome after breast conservation treatment with radiation for mammographically detected ductal carcinoma in-situ of the breast. Cancer 2005 103 6 1137 1146 2-s2.0-20044376865 10.1002/cncr.20886 (Pubitemid 40328083)
72. Solin L. J., Fourquet A., Vicini F. A., Taylor M., Haffty B., Strom E. A., Wai E., Pierce L. J., Marks L. B., Bartelink H., Campana F., McNeese M. D., Jhingran A., Olivotto I. A., Bijker N., Hwang W. T., Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in-situ. European Journal of Cancer 2005 41 12 1715 1723 2-s2.0-23644462263 10.1016/j.ejca.2005.03.028 (Pubitemid 41132631)
73. Wapnir I. L., Dignam J. J., Fisher B., Mamounas E. P., Anderson S. J., Julian T. B., Land S. R., Margolese R. G., Swain S. M., Costantino J. P., Wolmark N., Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. Journal of the National Cancer Institute 2011 103 6 478 488 2-s2.0-79952845819 10.1093/jnci/djr027
74. Bijker N., Meijnen P. H., Bogaerts J., Radiotherapy in breast conserving treatment for ductal carcinoma in-situ (DCIS): ten year results of European organization for research and treatment of cancer (EORTC) randomized trial 10853. Breast Cancer Research and Treatment 2005 94, supplement 1, article A7
75. Houghton J., George W. D., Cuzick J., Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in-situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. The Lancet 2003 362 9378 95 102 (Pubitemid 36831018)
76. Cuzick J., Sestak I., Pinder S., Ellis I., Forsyth S., Bundred N. J., Forbes J. F., Bishop H., Fentiman I., George W., Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. The Lancet Oncology 2011 12 1 21 29 2-s2.0-78650700810 10.1016/S1470-2045(10)70266-7
77. Emdin S. O., Granstrand B., Ringberg A., Sandelin K., SweDCIS: radiotherapy after sector resection for ductal carcinoma in-situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncologica 2006 45 5 536 543 10.1080/02841860600681569 (Pubitemid 44167203)
78. Goodwin A., Parker S., Ghersi D., Wilcken N., Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews 2009 4 2-s2.0-70049102551 10.1002/14651858.CD000563.pub5 CD000563
79. Viani G. A., Stefano E. J., Afonso S. L., Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiation Oncology 2007 2 1, article 28 2-s2.0-34548319130 10.1186/1748-717X-2-28
80. Fowble B., Silverstein M. J., Recht A., Lagios M., Overview of conservative surgery and radiation therapy: ductal carcinoma in-situ. Ductal Carcinoma In-situ of the Breast 2002 2nd Philadelphia, Pa, USA Lippincott Williams & Wilkins 287 302
81. Abe O., Abe R., Asaishi K., Enomoto K., Hattori T., Iino Y., Kikuchi K., Koyama H., Sawa K., Uchino J., Yoshida M., Van de Velde A. O., Vermorken J. B., Foroglou P., Giokas G., Lissaios B., Harvey V. J., Holdaway T. M., Kay R. G., Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. The New England Journal of Medicine 1995 333 22 1444 1455 10.1056/NEJM199511303332202
82. Overgaard M., Hansen P. S., Overgaard J., Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. The New England Journal of Medicine 1997 337 14 949 955 (Pubitemid 27425950)
83. Overgaard M., Jensen M. B., Overgaard J., Hansen P. S., Rose C., Andersson M., Kamby C., Kjær M., Gadeberg C. C., Rasmussen B. B., Blichert-Toft M., Mouridsen H. T., Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: danish breast-cancer cooperative group DBCG 82c randomised trial. The Lancet 1999 353 9165 1641 1648 2-s2.0-0033562626 10.1016/S0140-6736(98)09201-0 (Pubitemid 29224519)
84. Yerushalmi R., Sulkes A., Mishaeli M., Neumann A., Dinerman M., Sulkes J., Rizel S., Yarom N., Gutman H., Fenig E., Radiation treatment for ductal carcinoma in-situ (DCIS): is a boost to the tumor bed necessary? Neoplasma 2006 53 6 507 510 2-s2.0-33846400859 (Pubitemid 46133512)
85. Vaidya J. S., Partial breast irradiation using targeted intraoperative radiotherapy (Targit). Nature Clinical Practice Oncology 2007 4 7 384 385 2-s2.0-34447254059 10.1038/ncponc0850 (Pubitemid 47039685)
86. Vicini F., Beitsch P. D., Quiet C. A., Keleher A. J., Garcia D., Snider H. C., Gittleman M. A., Zannis V. J., Kuerer H. M., Lyden M., Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American society of breast surgeons mammosite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 2008 112 4 758 766 2-s2.0-39049143525 10.1002/cncr.23227 (Pubitemid 351240569)
87. Israel P. Z., Vicini F., Robbins A. B., Shroff P., McLaughlin M., Grier K., Lyden M., Ductal carcinoma in situ of the breast treated with accelerated partial breast irradiation using balloon-based brachytherapy. Annals of Surgical Oncology 2010 17 11 2940 2944 10.1245/s10434-010-1044-x
88. Hughes L. L., Wang M., Page D. L., Gray R., Solin L. J., Davidson N. E., Lowen M. A., Ingle J. N., Recht A., Wood W. C., Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the eastern cooperative oncology group. Journal of Clinical Oncology 2009 27 32 5319 5324 2-s2.0-73949085809 10.1200/JCO.2009.21.8560
89. Motwani S. B., Goyal S., Moran M. S., Chhabra A., Haffty B. G., Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194. Cancer 2011 117 6 1156 1162 2-s2.0-79952395233 10.1002/cncr.25623
90. Fisher B., Dignam J., Wolmark N., Wickerham D. L., Fisher E. R., Mamounas E., Smith R., Begovic M., Dimitrov N. V., Margolese R. G., Kardinal C. G., Kavanah M. T., Fehrenbacher L., Oishi R. H., Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial. The Lancet 1999 353 9169 1993 2000 2-s2.0-0033549344 10.1016/S0140-6736(99)05036-9 (Pubitemid 29271743)
91. Fisher B., Land S., Mamounas E., Silverstein M. J., Recht A., Lagios M., Prevention of invasive breast cancer in women with ductal carcinoma in-situ: an update of the national surgical adjuvant breast and bowel project experience. Ductal Carcinoma In-situ of the Breast 2002 2nd Philadelphia, Pa, USA Lippincott Williams & Wilkins 432 446
92. Allred D. C., Bryant J., Lano S., Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: findings from NSABP protocol B-24. Breast Cancer Research and Treatment 2002 76, supplement 1, article A30 536
93. Hu M., Peluffo G., Chen H., Gelman R., Schnitt S., Polyak K., Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proceedings of the National Academy of Sciences of the United States of America 2009 106 9 3372 3377 2-s2.0-62549099627 10.1073/pnas.0813306106
94. Schnitt S. J., The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin. Breast Cancer Research 2009 11 1, article 101 2-s2.0-67549115421 10.1186/bcr2228
95. Bundred N. J., Cramer A., Morris J., Renshaw L., Cheung K. L., Flint P., Johnson R., Young O., Landberg G., Grassby S., Turner L., Baildam A., Barr L., Dixon J. M., Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the erisac randomized placebo-controlled trial. Clinical Cancer Research 2010 16 5 1605 1612 2-s2.0-77649140377 10.1158/1078-0432.CCR-09-1623
96. Yen T. W. F., Hunt K. K., Ross M. I., Mirza N. Q., Babiera G. V., Meric-Bernstam F., Singletary S. E., Symmans W. F., Giordano S. H., Feig B. W., Ames F. C., Kuerer H. M., Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in-situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. Journal of the American College of Surgeons 2005 200 4 516 526 2-s2.0-20144387446 10.1016/j.jamcollsurg.2004.11.012 (Pubitemid 40432319)
97. Dillon M., McDermott E., Quinn C., O'Doherty A., O'Higgins N., Hill A., Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. Journal of Surgical Oncology 2006 93 7 559 563 2-s2.0-33744460728 10.1002/jso.20445 (Pubitemid 43806991)
98. Veronesi P., Intra M., Vento A. R., Naninato P., Caldarella P., Paganelli G., Viale G., Sentinel lymph node biopsy for localised ductal carcinoma in-situ? The Breast Journal 2005 14 6 520 522 2-s2.0-28044437506 10.1016/j.breast.2005.08.007 (Pubitemid 41683574)
99. Julian T. B., Land S. R., Fourchotte V., Haile S. R., Fisher E. R., Mamounas E. P., Costantino J. P., Wolmark N., Is sentinel node biopsy necessary in conservatively treated DCIS? Annals of Surgical Oncology 2007 14 8 2202 2208 2-s2.0-34547449160 10.1245/s10434-007-9353-4 (Pubitemid 47174907)
100. Warren J. L., Weaver D. L., Bocklage T., The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS. A population-based analysis. Cancer 2005 104 1840 1848 (Pubitemid 41513166)
101. Silverstein M. J., Lagios M. D., Martino S., Lewinsky B. S., Craig P. H., Beron P. J., Gamagami P., Waisman J. R., Outcome after invasive local recurrence in patients with ductal carcinoma in-situ of the breast. Journal of Clinical Oncology 1998 16 4 1367 1373 2-s2.0-0031923867 (Pubitemid 28175753)
102. Cutuli B., Borel C., Dhermain F., Magrini S. M., Wasserman T. H., Bogart J. A., Provencio M., De Lafontan B., De La Rochefordiere A., Cellai E., Graic Y., Kerbrat P., Alzieu C., Teissier E., Dilhuydy J. M., Mignotte H., Velten M., Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Radiotherapy and Oncology 2001 59 3 247 255 2-s2.0-0035370970 10.1016/S0167-8140(01)00337-1 (Pubitemid 32429572)
103. Cutuli B., Dilhuydy J. M., De Lafontan B., Berlie J., Lacroze M., Lesaunier F., Graic Y., Tortochaux J., Resbeut M., Lesimple T., Gamelin E., Campana F., Reme-Saumon M., Moncho-Bernier V., Cuilliere J. C., Marchal C., De Gislain G., N'Guyen T. D., Teissier E., Veiten M., Ductal carcinoma in-situ of the male breast: analysis of 31 cases. European Journal of Cancer A 1997 33 1 35 38 2-s2.0-0031037805 10.1016/S0959-8049(96)00436-4 (Pubitemid 27099564)
104. Hittmair A. P., Lininger R. A., Tavassoli F. A., Ductal carcinoma in-situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma: a preliminary report. Cancer 1998 83 10 2139 2149 10.1002/(SICI)1097-0142(19981115)83:102139::AID- CNCR12>3.0.CO;2-F (Pubitemid 28525395)
105. Head J. F., Elliott R. L., Stereotactic radiofrequency ablation: a minimally invasive technique for nonpalpable breast cancer in postmenopausal patients. Cancer Epidemiology 2009 33 3-4 300 305 2-s2.0-70349820181 10.1016/j.canep.2009.07.007